211 related articles for article (PubMed ID: 35863698)
21. PRDM10 RCC: A Birt-Hogg-Dubé-like Syndrome Associated With Lipoma and Highly Penetrant, Aggressive Renal Tumors Morphologically Resembling Type 2 Papillary Renal Cell Carcinoma.
Schmidt LS; Vocke CD; Ricketts CJ; Blake Z; Choo KK; Nielsen D; Gautam R; Crooks DR; Reynolds KL; Krolus JL; Bashyal M; Karim B; Cowen EW; Malayeri AA; Merino MJ; Srinivasan R; Ball MW; Zbar B; Marston Linehan W
Urology; 2023 Sep; 179():58-70. PubMed ID: 37331486
[TBL] [Abstract][Full Text] [Related]
22. Molecular genetics and clinical features of Birt-Hogg-Dubé syndrome.
Schmidt LS; Linehan WM
Nat Rev Urol; 2015 Oct; 12(10):558-69. PubMed ID: 26334087
[TBL] [Abstract][Full Text] [Related]
23. Knockdown of Slingshot 2 (SSH2) serine phosphatase induces Caspase3 activation in human carcinoma cell lines with the loss of the Birt-Hogg-Dubé tumour suppressor gene (FLCN).
Lu X; Boora U; Seabra L; Rabai EM; Fenton J; Reiman A; Nagy Z; Maher ER
Oncogene; 2014 Feb; 33(8):956-65. PubMed ID: 23416984
[TBL] [Abstract][Full Text] [Related]
24. Birt-Hogg-Dube syndrome is a novel ciliopathy.
Luijten MN; Basten SG; Claessens T; Vernooij M; Scott CL; Janssen R; Easton JA; Kamps MA; Vreeburg M; Broers JL; van Geel M; Menko FH; Harbottle RP; Nookala RK; Tee AR; Land SC; Giles RH; Coull BJ; van Steensel MA
Hum Mol Genet; 2013 Nov; 22(21):4383-97. PubMed ID: 23784378
[TBL] [Abstract][Full Text] [Related]
25. Birt-Hogg-Dubé renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression.
Klomp JA; Petillo D; Niemi NM; Dykema KJ; Chen J; Yang XJ; Sääf A; Zickert P; Aly M; Bergerheim U; Nordenskjöld M; Gad S; Giraud S; Denoux Y; Yonneau L; Méjean A; Vasiliu V; Richard S; MacKeigan JP; Teh BT; Furge KA
BMC Med Genomics; 2010 Dec; 3():59. PubMed ID: 21162720
[TBL] [Abstract][Full Text] [Related]
26. A case of Birt-Hogg-Dubé syndrome implying reduced or no wild-type folliculin without mutated protein is pathogenic.
Enomoto Y; Namba Y; Hoshika Y; Komemushi Y; Mitani K; Kume H; Kobayashi E; Miyama Y; Homma Y; Ushiku T; Seyama K
Eur J Med Genet; 2020 Apr; 63(4):103820. PubMed ID: 31778855
[TBL] [Abstract][Full Text] [Related]
27. Renal tumour suppressor function of the Birt-Hogg-Dubé syndrome gene product folliculin.
Hudon V; Sabourin S; Dydensborg AB; Kottis V; Ghazi A; Paquet M; Crosby K; Pomerleau V; Uetani N; Pause A
J Med Genet; 2010 Mar; 47(3):182-9. PubMed ID: 19843504
[TBL] [Abstract][Full Text] [Related]
28. Inactivation of the FLCN tumor suppressor gene induces TFE3 transcriptional activity by increasing its nuclear localization.
Hong SB; Oh H; Valera VA; Baba M; Schmidt LS; Linehan WM
PLoS One; 2010 Dec; 5(12):e15793. PubMed ID: 21209915
[TBL] [Abstract][Full Text] [Related]
29. H255Y and K508R missense mutations in tumour suppressor folliculin (FLCN) promote kidney cell proliferation.
Hasumi H; Hasumi Y; Baba M; Nishi H; Furuya M; Vocke CD; Lang M; Irie N; Esumi C; Merino MJ; Kawahara T; Isono Y; Makiyama K; Warner AC; Haines DC; Wei MH; Zbar B; Hagenau H; Feigenbaum L; Kondo K; Nakaigawa N; Yao M; Metwalli AR; Marston Linehan W; Schmidt LS
Hum Mol Genet; 2017 Jan; 26(2):354-366. PubMed ID: 28007907
[TBL] [Abstract][Full Text] [Related]
30. Birt-Hogg-Dube syndrome: clinicopathological features of the lung.
Furuya M; Nakatani Y
J Clin Pathol; 2013 Mar; 66(3):178-86. PubMed ID: 23223565
[TBL] [Abstract][Full Text] [Related]
31. Benign clear cell "sugar" tumor of the lung in a patient with Birt-Hogg-Dubé syndrome: a case report.
Gunji-Niitsu Y; Kumasaka T; Kitamura S; Hoshika Y; Hayashi T; Tokuda H; Morita R; Kobayashi E; Mitani K; Kikkawa M; Takahashi K; Seyama K
BMC Med Genet; 2016 Nov; 17(1):85. PubMed ID: 27871249
[TBL] [Abstract][Full Text] [Related]
32. Novel germline mutations in FLCN gene identified in two Chinese patients with Birt-Hogg-Dubé syndrome.
Li T; Ning X; He Q; Gong K
Chin J Cancer; 2017 Jan; 36(1):4. PubMed ID: 28069055
[TBL] [Abstract][Full Text] [Related]
33. Loss of FLCN-FNIP1/2 induces a non-canonical interferon response in human renal tubular epithelial cells.
Glykofridis IE; Knol JC; Balk JA; Westland D; Pham TV; Piersma SR; Lougheed SM; Derakhshan S; Veen P; Rooimans MA; van Mil SE; Böttger F; Poddighe PJ; van de Beek I; Drost J; Zwartkruis FJ; de Menezes RX; Meijers-Heijboer HE; Houweling AC; Jimenez CR; Wolthuis RM
Elife; 2021 Jan; 10():. PubMed ID: 33459596
[TBL] [Abstract][Full Text] [Related]
34. Detection of
Liu L; Yang K; Wang X; Shi Z; Yang Y; Yuan Y; Guo T; Xiao X; Luo H
Biomed Res Int; 2017; 2017():8751384. PubMed ID: 28785590
[TBL] [Abstract][Full Text] [Related]
35. Pulmonary cysts of Birt-Hogg-Dubé syndrome: a clinicopathologic and immunohistochemical study of 9 families.
Furuya M; Tanaka R; Koga S; Yatabe Y; Gotoda H; Takagi S; Hsu YH; Fujii T; Okada A; Kuroda N; Moritani S; Mizuno H; Nagashima Y; Nagahama K; Hiroshima K; Yoshino I; Nomura F; Aoki I; Nakatani Y
Am J Surg Pathol; 2012 Apr; 36(4):589-600. PubMed ID: 22441547
[TBL] [Abstract][Full Text] [Related]
36. Splice-site mutation causing partial retention of intron in the FLCN gene in Birt-Hogg-Dubé syndrome: a case report.
Furuya M; Kobayashi H; Baba M; Ito T; Tanaka R; Nakatani Y
BMC Med Genomics; 2018 May; 11(1):42. PubMed ID: 29720200
[TBL] [Abstract][Full Text] [Related]
37. A Case of Birt-Hogg-Dubé (BHD) Syndrome Harboring a Novel Folliculin (FLCN) Gene Mutation.
Yukawa T; Fukazawa T; Yoshida M; Morita I; Kato K; Monobe Y; Furuya M; Naomoto Y
Am J Case Rep; 2016 Oct; 17():788-792. PubMed ID: 27780965
[TBL] [Abstract][Full Text] [Related]
38. Clinical Features, Genetics and Potential Therapeutic Approaches for Birt-Hogg-Dubé Syndrome.
Schmidt LS; Linehan WM
Expert Opin Orphan Drugs; 2015; 3(1):15-29. PubMed ID: 26581862
[TBL] [Abstract][Full Text] [Related]
39. Kidney-targeted Birt-Hogg-Dube gene inactivation in a mouse model: Erk1/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys.
Baba M; Furihata M; Hong SB; Tessarollo L; Haines DC; Southon E; Patel V; Igarashi P; Alvord WG; Leighty R; Yao M; Bernardo M; Ileva L; Choyke P; Warren MB; Zbar B; Linehan WM; Schmidt LS
J Natl Cancer Inst; 2008 Jan; 100(2):140-54. PubMed ID: 18182616
[TBL] [Abstract][Full Text] [Related]
40. Negative regulation of EGFR signalling by the human folliculin tumour suppressor protein.
Laviolette LA; Mermoud J; Calvo IA; Olson N; Boukhali M; Steinlein OK; Roider E; Sattler EC; Huang D; Teh BT; Motamedi M; Haas W; Iliopoulos O
Nat Commun; 2017 Jun; 8():15866. PubMed ID: 28656962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
